PharmaCyte Biotech, Inc.
PMCB · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Market Cap | $9,089 | $20,312 | $56,908 | $36,166 |
| - Cash | $15,172 | $50,180 | $68,040 | $85,401 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$6,083 | -$29,868 | -$11,132 | -$49,234 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $30,656 | $6,854 | -$4,316 | -$4,239 |
| % Margin | – | – | – | – |
| Net Income | $30,656 | $334 | -$4,316 | -$4,239 |
| % Margin | – | – | – | – |
| EPS Diluted | 3.19 | -1.8 | -0.83 | -0.79 |
| % Growth | 277.2% | -116.9% | -5.1% | – |
| Operating Cash Flow | -$2,978 | -$2,151 | -$3,794 | -$4,117 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,978 | -$2,151 | -$3,794 | -$4,117 |